Publications

Development of CEDRIC-HIV

1. Mbuagbaw L, Ongolo-Zogo C, Mendoza OC, Zani B, Morfaw F, Nyambi A, Wang A, Kiflen M, El-Kechen H, Leenus A, Youssef M, Rehman N, Hermans L, MacDonald V, Bertagnolio S. Guidelines are needed for studies of pre-treatment HIV drug resistance: a methodological study. BMC Medical Research Methodology 2021, 21(1):76.
2. Garcia C, Rehman N, Lawson DO, Djiadeu P, Mbuagbaw L: Developing Reporting Guidelines for Studies of HIV Drug Resistance Prevalence: Protocol for a Mixed Methods Study. JMIR Res Protoc 2022, 11(5):e35969.
3. Garcia C, Holbrook A, Djiadeu P, Alvarez E, Matos Silva J, Mbuagbaw L. Developing a reporting item checklist for studies of HIV drug resistance prevalence or incidence: a mixed methods study. BMJ Open 2024;14:e080014. doi: 10.1136/bmjopen-2023-080014

CEDRIC-HIV Guidance Document

1. Mbuagbaw L, Garcia C, Brenner B, Cecchini D, Chakroun M, Djiadeu P, Holguin A, Mor O, Parkin N, Santoro MM, Ávila-Ríos S, Fokam J, Phillips A, Shafer RW, Jordan MR. Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use. The Lancet HIV 2023.

Editorials

1.  Blasioli E, Mbuagbaw L, Fokam J, Santoro MM. CEDRIC-HIV: la checklist per gli studi sulla resistenza ai farmaci anti-HIV. Epidemiol Prev. 2024, Jan-Feb;48(1):3. doi: 10.19191/EP24.1.A702.012. PMID: 38482779.